Abstract
Objective
To investigate the relationship of serum uric acid (Uacid) and derived parameters as predictors of insulin resistance (IR) and elevated liver transaminases in children and adolescents
Methods
Data of 1648 participants aged 10ā18 years was analyzed using nationwide survey. Logistic regression analysis was performed with IR and elevated liver transaminases as dependent variables, and odds ratios (ORs) and 95% confidence intervals (CIs) for tertiles 2 and 3 of each parameter in comparison to tertile 1, which served as the reference. Receiver operating characteristic (ROC) curves were generated to assess predictability of the parameters for IR and elevated liver transaminases.
Results
Hyperuricemia, IR, and elevated liver transaminases were significantly associated with each other. All Uacid and derived markers showed continuous increase in ORs and 95% CIs for IR and elevated liver transaminases across the tertiles of several biochemical and metabolic variables of interest (all pā<ā0.001), and were also significantly predictive in ROC curve. Overall, Uacid combined with obesity indices showed higher ORs and area under the curve (AUC) compared to Uacid alone. Uacid-body mass index (BMI) standard deviation score presented the largest AUC for IR. For elevated liver transaminases, Uacid-BMI and Uacid-waist-to-height ratio showed the largest AUC.
Conclusions
Uacid combined with obesity indices are robust markers for prediction of IR and elevated liver transaminases in children and adolescents. Uacid and derived markers have potential as simple markers which do not require fasting for screening of IR and elevated liver transaminases in children and adolescents.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Data availability
The data used in this study is available in the KNHANES website. https://knhanes.kdca.go.kr/knhanes/main.do.
References
Song K, Kim HS, Chae HW. Nonalcoholic fatty liver disease and insulin resistance in children. Clin Exp Pediatr. 2023;66:512ā9.
Kamani L, Rahat A, Yilmaz Y. Addressing the looming epidemic of metabolic dysfunction-associated steatotic liver disease in Pakistan: a call for action. Hepatol Forum. 2024;5:1ā2.
Bansal SK, Bansal MB. Review article: Pathogenesis of MASLD and MASH - role of insulin resistance and lipotoxicity. Aliment Pharmacol Ther. 2024. https://doi.org/10.1111/apt.17930.
Kalligeros M, Vassilopoulos A, Vassilopoulos S, Victor DW, Mylonakis E, Noureddin M Prevalence of Steatotic Liver Disease (MASLD, MetALD, and ALD) in the United States: NHANES 2017-2020. Clin Gastroenterol Hepatol. 2023. https://doi.org/10.1016/j.cgh.2023.11.003.
Schwimmer JB, Dunn W, Norman GJ, Pardee PE, Middleton MS, Kerkar N, et al. SAFETY study: alanine aminotransferase cutoff values are set too high for reliable detection of pediatric chronic liver disease. Gastroenterology 2010;138:1357ā64. 64 e1-2.
Kouvari M, Valenzuela-Vallejo L, Guatibonza-Garcia V, Polyzos SA, Deng Y, Kokkorakis M, et al. Liver biopsy-based validation, confirmation and comparison of the diagnostic performance of established and novel non-invasive steatotic liver disease indexes: Results from a large multi-center study. Metabolism. 2023;147:155666.
Zhang YN, Wang QQ, Chen YS, Shen C, Xu CF. Association between Serum Uric Acid to HDL-cholesterol ratio and nonalcoholic fatty liver disease in lean chinese adults. Int J Endocrinol. 2020;2020:5953461.
Song K, Lee HW, Choi HS, Park G, Lee HS, Kim SJ, et al. Comparison of the modified TyG indices and other parameters to predict non-alcoholic fatty liver disease in youth. Biol (Basel). 2022;11:685.
Song K, Park G, Lee HS, Choi Y, Oh JS, Choi HS, et al. Prediction of insulin resistance by modified triglyceride glucose indices in youth. Life (Basel). 2021;11:286.
Kang ES, Yun YS, Park SW, Kim HJ, Ahn CW, Song YD, et al. Limitation of the validity of the homeostasis model assessment as an index of insulin resistance in Korea. Metabolism. 2005;54:206ā11.
Ha J, Oh YR, Kang E, Nam HK, Rhie YJ, Lee KH. Single Point Insulin Sensitivity Estimator for predicting type 2 diabetes mellitus in obese adolescents. Ann Pediatr Endocrinol Metab. 2022;27:201ā6.
Sertoglu E, Ercin CN, Celebi G, Gurel H, Kayadibi H, Genc H, et al. The relationship of serum uric acid with non-alcoholic fatty liver disease. Clin Biochem. 2014;47:383ā8.
Zhou Y, Wei F, Fan Y. High serum uric acid and risk of nonalcoholic fatty liver disease: A systematic review and meta-analysis. Clin Biochem. 2016;49:636ā42.
Khamseh ME, Malek M, Abbasi R, Taheri H, Lahouti M, Alaei-Shahmiri F. Triglyceride glucose index and related parameters (triglyceride glucose-body mass index and triglyceride glucose-waist circumference) identify nonalcoholic fatty liver and liver fibrosis in individuals with overweight/obesity. Metab Syndr Relat Disord. 2021;19:167ā73.
Lim J, Kim J, Koo SH, Kwon GC. Comparison of triglyceride glucose index, and related parameters to predict insulin resistance in Korean adults: An analysis of the 2007-2010 Korean National Health and Nutrition Examination Survey. PLoS One. 2019;14:e0212963.
Sookoian S, Pirola CJ. The serum uric acid/creatinine ratio is associated with nonalcoholic fatty liver disease in the general population. J Physiol Biochem. 2023;79:891ā9.
Kweon S, Kim Y, Jang MJ, Kim Y, Kim K, Choi S, et al. Data resource profile: the Korea National Health and Nutrition Examination Survey (KNHANES). Int J Epidemiol. 2014;43:69ā77.
Kim JH, Yun S, Hwang SS, Shim JO, Chae HW, Lee YJ, et al. The 2017 Korean National Growth Charts for children and adolescents: development, improvement, and prospects. Korean J Pediatr. 2018;61:135ā49.
Roberts WC. The Friedewald-Levy-Fredrickson formula for calculating low-density lipoprotein cholesterol, the basis for lipid-lowering therapy. Am J Cardiol. 1988;62:345ā6.
Yi KH, Hwang JS, Kim EY, Lee SH, Kim DH, Lim JS. Prevalence of insulin resistance and cardiometabolic risk in Korean children and adolescents: a population-based study. Diabetes Res Clin Pr. 2014;103:106ā13.
Song K, Park G, Lee HS, Lee M, Lee HI, Ahn J, et al. Trends in prediabetes and non-alcoholic fatty liver disease associated with abdominal obesity among korean children and adolescents: based on the Korea National Health and Nutrition Examination Survey between 2009 and 2018. Biomedicines. 2022;10:584.
Uric Acid, Serum - Mayo Clinic Laboratories, Pediatric Catalog. 2021. https://pediatric.testcatalog.org/show/URIC.
Kocak MZ, Aktas G, Erkus E, Sincer I, Atak B, Duman T. Serum uric acid to HDL-cholesterol ratio is a strong predictor of metabolic syndrome in type 2 diabetes mellitus. Rev Assoc Med Bras (1992). 2019;65:9ā15.
She D, Xu W, Liu J, Zhang Z, Fang P, Li R, et al. Serum uric acid to creatinine ratio and risk of metabolic syndrome in patients with overweight/obesity. Diabetes Metab Syndr Obes. 2023;16:3007ā17.
Zhong D, Liu D, Guo Y, Huang H, Li L, Wu F, et al. Association of the serum uric acid to creatinine ratio with metabolic syndrome in the middle age and older population in China. Front Endocrinol (Lausanne). 2022;13:1060442.
Niu Y, Tang Q, Zhao X, Zhao X, Mao X, Sheng J, et al. Obesity-induced insulin resistance is mediated by high uric acid in obese children and adolescents. Front Endocrinol (Lausanne). 2021;12:773820.
Mosca A, Nobili V, De Vito R, Crudele A, Scorletti E, Villani A, et al. Serum uric acid concentrations and fructose consumption are independently associated with NASH in children and adolescents. J Hepatol. 2017;66:1031ā6.
Kim A, Yang HR, Cho JM, Chang JY, Moon JS, Ko JS. A nomogram for predicting non-alcoholic fatty liver disease in obese children. Pediatr Gastroenterol Hepatol Nutr. 2020;23:276ā85.
Di Bonito P, Valerio G, Licenziati MR, Di Sessa A, Miraglia Del Giudice E, Morandi A, et al. Uric acid versus metabolic syndrome as markers of fatty liver disease in young people with overweight/obesity. Diabetes Metab Res Rev. 2022;38:e3559.
Kim HY, Kim JH. Temporal trends in the prevalence of metabolically healthy overweight and obesity in Korean youth: data from the Korea National Health and Nutrition Examination Survey 2011-2019. Ann Pediatr Endocrinol Metab. 2022;27:134ā41.
Kojta I, Chacinska M, Blachnio-Zabielska A. Obesity, bioactive lipids, and adipose tissue inflammation in insulin resistance. Nutrients. 2020;12:1305.
Jung UJ, Choi MS. Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease. Int J Mol Sci. 2014;15:6184ā223.
Choe J, Kim J, Moon JS. Cutoff values of body mass index for severe obesity in Korean children and adolescents: the 99th percentile versus 120% of the 95th percentile. Ann Pediatr Endocrinol Metab. 2023;28:131ā7.
Styne DM, Arslanian SA, Connor EL, Farooqi IS, Murad MH, Silverstein JH, et al. Pediatric Obesity-Assessment, Treatment, and Prevention: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2017;102:709ā57.
Fabbrini E, Sullivan S, Klein S. Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. Hepatology. 2010;51:679ā89.
Peng J, Wu F, Tian H, Yang H, Zheng Y, Deng Z, et al. Clinical characteristics of and risk factors for small airway dysfunction detected by impulse oscillometry. Respir Med. 2021;190:106681.
Putri RR, Casswall T, Hagman E. Risk and protective factors of non-alcoholic fatty liver disease in paediatric obesity: A nationwide nested case-control study. Clin Obes. 2022;12:e12502.
Song K, Yang J, Lee HS, Kim SJ, Lee M, Suh J, et al. Changes in the prevalences of obesity, abdominal obesity, and non-alcoholic fatty liver disease among korean children during the COVID-19 outbreak. Yonsei Med J. 2023;64:269ā77.
Ismaiel A, Hosiny BE, Ismaiel M, Leucuta DC, Popa SL, Catana CS, et al. Waist to height ratio in nonalcoholic fatty liver disease - Systematic review and meta-analysis. Clin Res Hepatol Gastroenterol. 2023;47:102160.
Hoofnagle AN, Vaisar T, Mitra P, Chait A. HDL lipids and insulin resistance. Curr Diab Rep. 2010;10:78ā86.
Khovidhunkit W, Kim MS, Memon RA, Shigenaga JK, Moser AH, Feingold KR, et al. Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. J Lipid Res. 2004;45:1169ā96.
van der Poorten D, Milner KL, Hui J, Hodge A, Trenell MI, Kench JG, et al. Visceral fat: a key mediator of steatohepatitis in metabolic liver disease. Hepatology. 2008;48:449ā57.
Zhu W, Liang A, Shi P, Yuan S, Zhu Y, Fu J, et al. Higher serum uric acid to HDL-cholesterol ratio is associated with onset of non-alcoholic fatty liver disease in a non-obese Chinese population with normal blood lipid levels. BMC Gastroenterol. 2022;22:196.
Zhou X, Xu J. Association between serum uric acid-to-high-density lipoprotein cholesterol ratio and insulin resistance in patients with type 2 diabetes mellitus. J Diabetes Investig. 2024;15:113ā20.
Funding
This study was supported by a faculty research grant from Yonsei University College of Medicine (6-2021-0150).
Author information
Authors and Affiliations
Contributions
Youngha Choi was responsible for conceptualization, methodology, formal analysis, investigation and writing - original draft. Hyejin Yang was responsible for resources, data curation, formal analysis and writing - original draft. Soyoung Jeon was responsible for resources, data curation, formal analysis and writing - original draft. Kyoung Won Cho, Seo Jung Kim and Sujin Kim was responsible for conceptualization, methodology and writing - review & editing. Myeongseob Lee was responsible for methodology, investigation and writing - review & editing. Junghwan Suh was responsible for conceptualization, methodology and writing - review & editing. Hyun Wook Chae was responsible for conceptualization, methodology and writing - review & editing. Ho-Seong Kim was responsible for supervision and writing - review & editing. Kyungchul song was responsible for conceptualization, methodology, formal analysis, investigation and writing - review & editing.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Ethical approval
The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Institutional Review Board of Yonsei University Gangnam Severance Hospital (IRB, 9-2023-0215).
Informed consent
Informed consent was obtained from all subjects involved in the study.
Additional information
Publisherās note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
41430_2024_1475_MOESM1_ESM.docx
Supplementary Table S1. Comparison of areas under receiver operating curves among each parameter for predicting IR and ALT elevation
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Choi, Y., Yang, H., Jeon, S. et al. Prediction of insulin resistance and elevated liver transaminases using serum uric acid and derived markers in children and adolescents. Eur J Clin Nutr (2024). https://doi.org/10.1038/s41430-024-01475-z
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41430-024-01475-z